Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Natera, Inc.NTRA · Entity 2635 | Director | July 15, 2026 | July 18, 2026 |
| Senti Biosciences Holdings, Inc.DYNS · Entity 7935 | Chief Business Officer | May 25, 2021 | May 26, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Natera, Inc.
Report date July 15, 2026 · Filed July 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,663 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Sale · Disposed 135 · Balance 4,663 F1: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
Senti Biosciences Holdings, Inc.
Report date May 25, 2021 · Filed May 26, 2021
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2021 Filed Jun 3, 2021 00:17 UTC | Natera, Inc. NTRA · Entity 2635 | GrantStock Option (right to buy) · Derivative | 2,614 | $0.00 Strike: $94.14 | $0.00 |
DisclosureSEC source: 0001415889-21-002776 · form4-06022021_050604.xml · derivative · entry 3 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,614 Underlying: Common Stock · 2,614 shares Expires 2031-05-27 F3 · derivative.exercise_date: The option shares shall vest and become exercisable in full on May 25, 2022. The option shares will become fully vested and exercisable in the event that the Issuer is subject to a change in control. Read SEC document |
| May 28, 2021 Filed Jun 3, 2021 00:17 UTC | Natera, Inc. NTRA · Entity 2635 | GrantRestricted Stock Unit · Derivative | 1,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-002776 · form4-06022021_050604.xml · derivative · entry 2 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,307 Underlying: Common Stock · 1,307 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU shall vest in full on May 25, 2022. The RSU will become fully vested in the event that the Issuer is subject to a change in control. F2 · derivative.expiration_date: The RSU shall vest in full on May 25, 2022. The RSU will become fully vested in the event that the Issuer is subject to a change in control. Read SEC document |
| May 28, 2021 Filed Jun 3, 2021 00:17 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 2,856 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-002776 · form4-06022021_050604.xml · nonDerivative · entry 1 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:58 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $32.15 | $0.00 |
DisclosureSEC source: 0001415889-21-001288 · form4-03032021_030309.xml · derivative · entry 3 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 8,000 shares Expires 2029-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option shares vest over three years. A third of the option shares vested and became exercisable on August 15, 2020 and the remaining shares vest in 2 equal annual installments thereafter. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:58 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 6,000 | $122.23 | $733,408.20 |
DisclosureSEC source: 0001415889-21-001288 · form4-03032021_030309.xml · nonDerivative · entry 2 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:58 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 8,000 | $32.15 | $257,200.00 |
DisclosureSEC source: 0001415889-21-001288 · form4-03032021_030309.xml · nonDerivative · entry 1 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 00:06 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $32.15 | $0.00 |
DisclosureSEC source: 0001179110-20-011138 · edgar.xml · derivative · entry 3 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 3,000 shares Expires 2029-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option shares vest over three years. A third of the option shares vested and became exercisable on August 15, 2020 and the remaining shares vest in 2 equal annual installments thereafter. Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 00:06 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 3,000 | $83.48 | $250,425.00 |
DisclosureSEC source: 0001179110-20-011138 · edgar.xml · nonDerivative · entry 2 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 00:06 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 3,000 | $32.15 | $96,450.00 |
DisclosureSEC source: 0001179110-20-011138 · edgar.xml · nonDerivative · entry 1 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 22:42 UTC | Natera, Inc. NTRA · Entity 2635 | GrantStock Option (right to buy) · Derivative | 5,712 | $0.00 Strike: $40.93 | $0.00 |
DisclosureSEC source: 0001179110-20-007464 · edgar.xml · derivative · entry 2 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,712 Underlying: Common Stock · 5,712 shares Expires 2030-06-11 F3 · derivative.exercise_date: The option shares shall vest and become exercisable in full on May 28, 2021. The option shares will become fully vested and exercisable in the event that the Issuer is subject to a change in control. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 22:42 UTC | Natera, Inc. NTRA · Entity 2635 | GrantRestricted Stock Units · Derivative | 2,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007464 · edgar.xml · derivative · entry 1 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,856 Underlying: Common Stock · 2,856 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The RSU shall vest in full on May 28, 2021. The RSU will become fully vested in the event that the Issuer is subject to a change in control. F2 · derivative.expiration_date: The RSU shall vest in full on May 28, 2021. The RSU will become fully vested in the event that the Issuer is subject to a change in control. Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 23:13 UTC | Natera, Inc. NTRA · Entity 2635 | GrantStock Option (right to buy) · Derivative | 33,000 | $0.00 Strike: $32.15 | $0.00 |
DisclosureSEC source: 0001104659-19-052331 · a4.xml · derivative · entry 1 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires 2029-09-26 F1 · derivative.exercise_date: The option shares vest over three years. A third of the option shares vest and become exercisable on August 15, 2020 and the remaining shares vest on 2 equal annual installments thereafter. The initial option will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.